Study of glucose profiles with continuous glucose monitoring in adolescents with poorly controlled type 2 diabetes mellitus

Journal of Pediatric Endocrinology and Metabolism

Volumn 21, Issue 8, 2008, Pages 729-736

  Lu, Haiyan ^a   Castells, Salvador ^a   Hagerty, Dawn ^a   Quintos, J B ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

AUC; CGMS; Continuous glucose monitoring; Fructosamine; Glycemic excursion; HbAlc; Hyperglycemia; Hypoglycemia; Type 2 diabetes mellitus

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

EID: 52649142136     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2008.21.8.729     Document Type: Article

References (40)

1. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006; 160: 523-528.
2. Lee JM, Herman WH, McPheeters ML, Gurney JG. An epidemiologic profile of children with diabetes in the U.S. Diabetes Care 2006; 29: 420-421.
3. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000; 13 (Suppl 6): 1395-1402.
4. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998; 352: 837-853.
7. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
8. Gerich J. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003; 163: 1306-1316.
9. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997; 5: 294-315.
10. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, Pagano G, Bistoni S, Calabrese G, Santeusanio F, Leonetti F, Ribaudo M, Di Mario U, Annuzzi G, Genovese S, Riccardi G, Previti M, Cucinotta D, Giorgino F, Bellomo A, Giorgino R, Poscia A, Varalli M. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002; 25: 347-352.
11. Maia FFR, Araüjo LR. Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patients. Diabetes Res Clin Pract 2007; 75: 30-34.
12. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 2063; 20: 1012-1015.
13. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006; 7: 159-164.
14. Schaepelynck-Belicar P, Vague P, Simonin G, Lassmann-Vague V. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). Diabetes Metab 2003; 29: 608-612.
15. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111: 933-938.
16. Mastrototaro J. The MiniMed Continuous Glucose Monitoring System (CGMS). J Pediatr Endocrinol Metab 1999; 12 (Suppl 3): 751-758.
17. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990, 300: 230-235.
18. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26: 1153-1157.
19. Caduff A, Hirt E, Feldman Y, Ali Z, Heinemann L. First human experiments with a novel non-invasive, non-optical continuous glucose monitoring system. Biosens Bioelectron 2003; 19: 209-217.
20. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabet Med 2003; 20: 238-241.
21. Praet SF, Manders RJ, Meex RC, Lieverse AG, Stehouwer CD, Kuipers H, Keizer HA, van Loon LJ. Glycaemic instability is an underestimated problem in Type II diabetes. Clin Sci 2006; 111: 119-126.
22. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 2003; 5: 19-26.
23. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51: 724-733.
24. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54: 3592-3601.
25. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858-1862.
26. Streja D. Can continuous glucose monitoring provide objective documentation of hypoglycemia unawareness?. Endocr Pract 2005; 11: 83-90.
27. Evans JM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ 1999; 319: 83-86.
28. Conrad SC, Mastrototaro JJ, Gitelman SE. The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatr Endocrinol Metab 2004; 17: 281-288.
29. Weinzimer SA, Tamborlane WV, Chase HP, Garg SK. Continuous glucose monitoring in type 1 diabetes. Curr Diab Rep 2004; 4: 95-100.
30. Cameron FJ, Ambler GR. Does continuous glucose monitoring have clinical utility in contemporary management of diabetes? J Paediatr Child Health 2004; 40: 79-84.
31. Tavris DF, Shoaibi A. The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literature. Diabetes Technol Ther 2004; 6: 518-522.
32. Deiss D, Hartmann R, Hoeffe J, Kordonouri O. Assessment of glycernic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 2004; 5: 117-121.
33. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005; 28: 2361-2366.
34. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132.
35. Scognamiglio R, Negut C, Vigili S, Kreutzenberg D, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation 2005; 112: 179-184.
36. Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 2006; 16: 453-456.
37. American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2002; 25 (Suppl 1): 97-99.
38. Fiallo-Scharer R; Diabetes Research in Children Network Study Group. Eight-point glucose testing versus continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab, 2005; 90: 337-3391.
39. 1c in pediatric type 1 diabetic patients. Diabetes Care 2002; 25: 1840-1844.
40. 1c. Ann Clin Biochem 2002; 39: 516-517.